Discover and read the best of Twitter Threads about #Glaxosmith
Most recents (1)
- Pharma MNCs riding on innovation & operating in niche therapies (less competition), focus on few brand & enjoy premium pricing, 100% focus on India market.
- Indian cos; struggle with regulatory hurdles (US FDA), 70% revenue from overseas biz, currency & geopolitical risks.
- Indian cos; struggle with regulatory hurdles (US FDA), 70% revenue from overseas biz, currency & geopolitical risks.
Indian pharma companies are facing a lot of compliance issues. If current situation continues, they might not get approval of pending products which ultimately impact on topline of these companies
#Lupin
#AurobindoPharma
#Cipla
@caniravkaria @_N_U_P_K_Y
#Lupin
#AurobindoPharma
#Cipla
@caniravkaria @_N_U_P_K_Y
Pfizer Q2 sales 567crs vs 519 crs, net profits up 60% at 154 crs vs 96
As mentioned, Pharma MNCs are exceedingly doing well compared to Indian pharma players!!
#Pfizer
#Abbott
#Merck
#Sanofi
#Glaxosmith
As mentioned, Pharma MNCs are exceedingly doing well compared to Indian pharma players!!
#Pfizer
#Abbott
#Merck
#Sanofi
#Glaxosmith
